Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Go back to Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program| (NASDAQ: KALA) | Delayed: 0.60 +0.04 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.56 | 52 Week High | $ | |||
| Open | $0.57 | 52 Week Low | $ | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $ | |||
| Volume | 136,615 | |||||

